HIV pathogenesis : 25 years of progress and persistent challengesLEVY, Jay A.AIDS (London). 2009, Vol 23, Num 2, pp 147-160, issn 0269-9370, 14 p.Article

HIV infection: what should be considered in approaches for a cure?LEVY, Jay A; LEVY, Yves.AIDS (London). 2012, Vol 26, Num 17, pp 2253-2255, issn 0269-9370, 3 p.Article

CD4-independent infection of HIV and SIV: implications for envelope conformation and cell tropism in vivoBHATTACHARYA, Jayanta; PETERS, Paul J; CLAPHAM, Paul R et al.AIDS (Supplement). 2003, Vol 17, pp S35-S43, issn 1350-2840, SUP4Article

Growing in silence: selected regions and countries with expanding HIV/AIDS epidemicsGHYS, Peter D; SAIDEL, Tobi; HOANG TRAN VU et al.AIDS (Supplement). 2003, Vol 17, pp S45-S50, issn 1350-2840, SUP4Article

Protection from HIV/AIDS: the importance of innate immunityLEVY, Jay A; SCOTT, Iain; MACKEWICZ, Carl et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 108, Num 3, pp 167-174, issn 1521-6616, 8 p.Article

Cancer, sida : la qualité de vieJASMIN, Claude; LEVY, Jay-A; BEZ, Gabriel et al.1996, 284 p., isbn 2-908-60189-3Book

AIDS 2003: A Year in ReviewAUTRAN, Brigitte; COUNTINHO, Roel; LEVY, Jay et al.AIDS (Supplement). 2003, Vol 17, issn 1350-2840, 133 p., SUP4Serial Issue

New antiretroviral drugs and approaches to HIV treatmentPAREDES, Roger; CLOTET, Bonaventura.AIDS (Supplement). 2003, Vol 17, pp S85-S96, issn 1350-2840, SUP4Article

Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication, by Martínez et alCROWE, Suzanne.AIDS (Supplement). 2003, Vol 17, pp S103-SS105, issn 1350-2840, SUP4Article

Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy, by Dean et alWANKE, Christine.AIDS (Supplement). 2003, Vol 17, pp S112-S114, issn 1350-2840, SUP4Article

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patients, by Ghosn et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S117-S119, issn 1350-2840, SUP4Article

B cell activation in peripheral blood and lymph nodes during HIV infection, by Zamarchi et alCLERICI, Mario.AIDS (Supplement). 2003, Vol 17, pp S99-S101, issn 1350-2840, SUP4Article

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study, by Matthews et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S116-S117, issn 1350-2840, SUP4Article

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up, by Hogg et alMASTRO, Timothy D.AIDS (Supplement). 2003, Vol 17, pp S123-S124, issn 1350-2840, SUP4Article

Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania Pujades, by Rodríguez et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S128-S130, issn 1350-2840, SUP4Article

Use of laboratory tests and clinical symptoms for identification of primary HIV infectionHECHT, Frederick M; BUSCH, Michael P; RAWAL, Bhupat et al.AIDS (London). 2002, Vol 16, Num 8, pp 1119-1129, issn 0269-9370Article

Sex, Race, and Geographic Region Influence Clinical Outcomes Following Primary HIV-1 InfectionMEDITZ, Amie L; MAWHINNEY, Samantha; KILBY, J. Michael et al.The Journal of infectious diseases. 2011, Vol 203, Num 4, pp 442-451, issn 0022-1899, 10 p.Article

Effect of interleukin-2 plus highly active antiretroviral therapy on HIV-1 replication and proviral DNA (COSMIC trial), by Ling et alCROWE, Suzanne.AIDS (Supplement). 2003, Vol 17, pp S105-S107, issn 1350-2840, SUP4Article

Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG study A5047, by Fichtenbaum et alWANKE, Christine.AIDS (Supplement). 2003, Vol 17, pp S109-S110, issn 1350-2840, SUP4Article

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy, by Cohen et alHIRSCHEL, Bernard.AIDS (Supplement). 2003, Vol 17, pp S114-S116, issn 1350-2840, SUP4Article

Study of bias in antenatal clinic HIV-1 surveillance data in a high contraceptive prevalence population in sub-Saharan Africa, by Gregson et alMASTRO, Timothy D.AIDS (Supplement). 2003, Vol 17, pp S122-S123, issn 1350-2840, SUP4Article

Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection, by Mulherin et alHOGG, Robert S.AIDS (Supplement). 2003, Vol 17, pp S127-S128, issn 1350-2840, SUP4Article

Sacral epithelioid angiosarcoma associated with a bleeding diathesis and spinal epidural hematomaSANCHEZ-MEJIA, Rene O; OJEMANN, Steven G; SIMKO, Jeff et al.Journal of neurosurgery. Spine. 2006, Vol 4, Num 3, pp 246-250, issn 1547-5654, 5 p.Article

Immune activation set point during early HIV infection predicts subsequent CD4⁺ T-cell changes independent of viral loadDEEKS, Steven G; KITCHEN, Christina M. R; MCGRATH, Michael S et al.Blood. 2004, Vol 104, Num 4, pp 942-947, issn 0006-4971, 6 p.Article

Page / 3